Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bensimon

Showing results (411-420 of 415) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 415 results.
Science (New York, N.Y.)|April 25, 2024
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 2, 2023
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guidelineSam D Shemie, Lindsay C Wilson, Laura Hornby, et al.
Nature Genetics|July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisWouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 42

Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
Science (New York, N.Y.)|April 25, 2024
Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cellsFabian Offensperger, Gary Tin, Miquel Duran-Frigola, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 2, 2023
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guidelineSam D Shemie, Lindsay C Wilson, Laura Hornby, et al.
Nature Genetics|July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisWouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 42